These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
457 related items for PubMed ID: 27117614
21. Palovarotene Inhibits Heterotopic Ossification and Maintains Limb Mobility and Growth in Mice With the Human ACVR1(R206H) Fibrodysplasia Ossificans Progressiva (FOP) Mutation. Chakkalakal SA, Uchibe K, Convente MR, Zhang D, Economides AN, Kaplan FS, Pacifici M, Iwamoto M, Shore EM. J Bone Miner Res; 2016 Sep; 31(9):1666-75. PubMed ID: 26896819 [Abstract] [Full Text] [Related]
22. ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A. Hatsell SJ, Idone V, Wolken DM, Huang L, Kim HJ, Wang L, Wen X, Nannuru KC, Jimenez J, Xie L, Das N, Makhoul G, Chernomorsky R, D'Ambrosio D, Corpina RA, Schoenherr CJ, Feeley K, Yu PB, Yancopoulos GD, Murphy AJ, Economides AN. Sci Transl Med; 2015 Sep 02; 7(303):303ra137. PubMed ID: 26333933 [Abstract] [Full Text] [Related]
34. Skeletal malformations and developmental arthropathy in individuals who have fibrodysplasia ossificans progressiva. Towler OW, Shore EM, Kaplan FS. Bone; 2020 Jan 02; 130():115116. PubMed ID: 31655222 [Abstract] [Full Text] [Related]
35. The HIF-1α and mTOR Pathways Amplify Heterotopic Ossification. Wang H, Kaplan FS, Pignolo RJ. Biomolecules; 2024 Jan 24; 14(2):. PubMed ID: 38397384 [Abstract] [Full Text] [Related]
36. Neofunction of ACVR1 in fibrodysplasia ossificans progressiva. Hino K, Ikeya M, Horigome K, Matsumoto Y, Ebise H, Nishio M, Sekiguchi K, Shibata M, Nagata S, Matsuda S, Toguchida J. Proc Natl Acad Sci U S A; 2015 Dec 15; 112(50):15438-43. PubMed ID: 26621707 [Abstract] [Full Text] [Related]
37. Effects of FKBP12 and type II BMP receptors on signal transduction by ALK2 activating mutations associated with genetic disorders. Machiya A, Tsukamoto S, Ohte S, Kuratani M, Fujimoto M, Kumagai K, Osawa K, Suda N, Bullock AN, Katagiri T. Bone; 2018 Jun 15; 111():101-108. PubMed ID: 29551750 [Abstract] [Full Text] [Related]
38. A novel mutation of ALK2, L196P, found in the most benign case of fibrodysplasia ossificans progressiva activates BMP-specific intracellular signaling equivalent to a typical mutation, R206H. Ohte S, Shin M, Sasanuma H, Yoneyama K, Akita M, Ikebuchi K, Jimi E, Maruki Y, Matsuoka M, Namba A, Tomoda H, Okazaki Y, Ohtake A, Oda H, Owan I, Yoda T, Furuya H, Kamizono J, Kitoh H, Nakashima Y, Susami T, Haga N, Komori T, Katagiri T. Biochem Biophys Res Commun; 2011 Apr 01; 407(1):213-8. PubMed ID: 21377447 [Abstract] [Full Text] [Related]
39. TGF-Beta Induces Activin A Production in Dermal Fibroblasts Derived from Patients with Fibrodysplasia Ossificans Progressiva. de Ruiter RD, Wisse LE, Schoenmaker T, Yaqub M, Sánchez-Duffhues G, Eekhoff EMW, Micha D. Int J Mol Sci; 2023 Jan 24; 24(3):. PubMed ID: 36768622 [Abstract] [Full Text] [Related]